ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly verzenio — Worldwide revenue growth YoY (%) (%)
Form 10-Q / 10-K MD&A & Form 8-K Releases
Latest, Q2 2026
-1.0%
Period ended Jun 30, 2026
Change on a year earlier
-13.0 pts
12.0% in Q2 2025
History
27 quarters
Since Q3 2019
Sources
27
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Eli Lilly Verzenio — Worldwide revenue growth YoY (%) (%), quarterly Q3 2019–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med_verzenio_yoy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.